Chimaeric HBV core particles carrying a defined segment of Puumala hantavirus nucleocapsid protein evoke protective immunity in an animal model

Vaccine

Volumn 16, Issue 2-3, 1998, Pages 272-280

  Ulrich, Rainer ^a   Lundkvist, Åke ^b   Meisel, Helga ^a   Koletzki, Diana ^a   Brus Sjölander, Katarina ^b   Gelderblom, Hans R ^c   Borisova, Galina ^d   Schnitzler, Paul ^e   Darai, Gholamreza ^e   Krüger, Detlev H ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c ROBERT KOCH INSTITUTE   (Germany)

^d UNIVERSITY OF LATVIA   (Latvia)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Chimaeric virus like particles; Hantavirus; Protective immunity

Indexed keywords

HEPATITIS B CORE ANTIGEN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGENICITY; ARTICLE; CHIMERA; CONTROLLED STUDY; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; IMMUNITY; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; PUUMALA VIRUS; VOLE;

ANIMALS; ARVICOLINAE; HANTAVIRUS; HANTAVIRUS INFECTIONS; HEPATITIS B CORE ANTIGENS; NUCLEOCAPSID; RECOMBINANT FUSION PROTEINS; VIRAL VACCINES;

EID: 0031986095     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00172-2     Document Type: Article

References (59)

1. 1 Lundkvist, Å. and Niklasson, B. Hemorrhagic fever with renal syndrome and other hantavirus infections. Reviews of Medical Virology 1994, 4, 177-184.
2. 2 Plyusnin, A., Vapalahti, O. and Vaheri, A. Hantaviruses: genome structure, expression and evolution. Journal of General Virology 1996, 75, 405-409.
3. 3 Morse, S.S. and Schluederberg, A. Emerging viruses: The evolution of viruses and viral diseases. Journal of Infectious Diseases 1990, 162, 1-7.
4. 4 Nichol, S.T., Spiropoulou, C.T., Morzunov, S., Rollin, P.E., Ksiazek, T.G., Feldmann, H., Sanchez, A., Childs, J., Zaki, S. and Peters, C.J. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 1993, 262, 914-917.
5. 5 Schödel, F., Neckermann, G., Peterson, D., Fuchs, K., Fuller, S., Will, H. and Roggendorf, M. Immunization with recombinant woodchuck hepatitis virus nucleocapsid antigen or hepatitis B virus nucleocapsid antigen protects woodchucks from woodchuck hepatitis virus infection. Vaccine 1993, 11, 624-628.
6. 6 Ulmer, J.B., Donnelly, J.J., Parker, S.E., Rhodes, G.H., Feigner, P.L., Dwarki, V.J., Gromkowski, S.H., Deck, R.R., DeWitt, C.M., Friedman, A., Hawe, L.A., Leander, K.R., Martinez, D., Perry, H.C., Shiver, J.W., Montgomery, D.L and Liu, M.A. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993, 259, 1745-1749.
7. 7 Reip, A., Haring, B., Sibold, C., Stohwasser, R., Bautz, E.K.F., Darai, G., Meisel, H. and Krüger, D.H. Coding strategy of the S and M genome segments of a hantavirus representing a new subtype of the Puumala serotype. Archives of Virology 1995, 140, 2011-2026.
8. 8 Schmaljohn, C.S., Sugiyama, K., Schmaljohn, A.L. and Bishop, D.H.L. Baculovirus expression of the small genome segment of hantaan virus and potential use of the expressed nucleocapsid protein as a diagnostic antigen. Journal of General Virology 1988, 69, 777-786.
9. 9 Gött, P., Zöller, L., Yang, S., Stohwasser, R., Bautz, E.K.F. and Darai, G. Antigenicity of hantavirus nucleocapsid proteins expressed in E. coli. Virus Research 1991, 19, 1-16.
10. 10 Zöller, L., Yang, S., Gött, P., Bautz, E.K.F. and Darai, G. Use of recombinant nucleocapsid proteins of the Hantaan and Nephropathia epidemica serotypes of hantaviruses as immunodiagnostic antigens. Journal of Medical Virology 1993, 39, 200-207.
11. 11 Zöller, L.G., Yang, S., Gött, P., Bautz, E.K.F. and Darai, G. A novel μ-capture enzyme-linked immunosorbent assay based on recombinant proteins for sensitive and specific diagnosis of hemorrhagic fever with renal syndrome. Journal of Clinical Microbiology 1993, 31, 1194-1199.
12. 12 Zöller, L., Faulde, M., Meisel, H., Ruh, B., Kimming, P., Schelling, U., Zeier, M., Kulzer, P., Becker, C., Roggendorf, M., Bautz, E.K.F., Krüger, D.H. and Darai, G. Seroprevalence of hantavirus antibodies in Germany as determined by a novel recombinant enzyme immunoassay. European Journal of Clinical Microbiology and Infectious Diseases 1995, 14, 305-313.
13. 13 Vapalahti, O., Kallio-Kokko, H., Salonen, E.-M., Brummer-Korvenkontio, M. and Vaheri, A. Cloning and sequencing of Puumala virus Sotkamo strain S and M RNA segments: evidence for strain variation in hantaviruses and expression of the nucleocapsid protein. Journal of General Virology 1992, 73, 829-838.
14. 14 Vapalahti, O., Lundkvist, Å., Kallio-Kokko, H., Paukku, K., Julkunen, I., Lankinen, H. and Vaheri, A. Antigenic properties and diagnostic potential of Puumala virus nucleocapsid protein expressed in insect cells. Journal of Clinical Microbiology 1996, 34, 119-125.
15. 15 Wang, M., Rossi, C. and Schmaljohn, C.S. Expression of nonconserved regions of the S genome segments of three hantaviruses: evaluation of the expressed polypeptides for diagnosis of haemorrhagic fever with renal syndrome. Journal of General Virology 1993, 74, 1115-1124.
16. 16 Feldmann, H., Sanchez, A., Morzunov, S., Spiropoulou, C.F., Rollin, P.E., Ksiazek, T.G., Peters, C.J. and Nichol, S.T. Utilization of autopsy RNA for the synthesis of the nucleocapsid antigen of a newly recognized virus associated with hantavirus pulmonary syndrome. Virus Research 1993, 30, 351-367.
17. 17 Lundkvist, Å., Hörling, J. and Niklasson, B. The humoral response to Puumala virus infection (nephropathia epidemica) investigated by viral protein specific immunoassays. Archives of Virology 1993, 130, 121-130.
18. 18 Yoshimatsu, K., Arikawa, J. and Kariwa, H. Application of a recombinant baculovirus expressing hantavirus nucleoprotein as a diagnostic antigen in IFA test: Cross reactivities among 3 serotypes of hantavirus which causes hemorrhagic fever with renal syndrome (HFRS). Journal of Veterinary and Medical Science 1993, 55, 1047-1050.
19. 19 Schmaljohn, C.S., Chu, Y.-K., Schmaljohn, A.L. and Dalrymple, J.M. Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants. Journal of Virology 1990, 64, 3162-3170.
20. 20 Xu, X., Ruo, S.L, McCormick, J.B. and Fisher-Hoch, S.P. Immunity to hantavirus challenge in Meriones unguiculatus induced by vaccinia-vectored viral proteins. American Journal of Tropical Medicine and Hygiene 1992, 47, 397-404.
21. 21 Yoshimatsu, K., Yoo, Y.-C., Yoshida, R., Ishihara, C., Azuma, I. and Arikawa, J. Protective immunity of Hantaan virus nucleocapsid and envelope protein studied using baculovirus-expressed proteins. Archives of Virology 1993, 130, 365-376.
22. 22 Chu, Y.-K., Jennings, G.B. and Schmaljohn, C.S. A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul virus but not Puumala virus. Journal of Virology 1995, 69, 6417-6423.
23. 23 Schmaljohn, C. Prospects for vaccines to control viruses in the family Bunyaviridae. Reviews of Medical Virology 1994, 4, 185-196.
24. 24 Lundkvist, Å., Kallio-Kokko, H., Brus Sjölander, K., Lankinen, H., Niklasson, B., Vaheri, A. and Vapalahti, O. Characterization of Puumala virus nucleocapsid protein: Identification of B-cell epitopes and domains involved in protective immunity. Virology 1996, 216, 397-406.
25. 25 Elgh, F., Lundkvist, Å., Alexeyev, O.A., Wadell, G. and Juto, P. A major antigenic domain of the human humoral response to Puumala virus nucleocapsid protein is located at the aminoterminus. Journal of Virological Methods 1996, 59, 161-172.
26. 26 Gött, P., Zöller, L., Darai, G. and Bautz, E.K.F. A major antigenic domain of hantaviruses is located on the aminoproximal site of the viral nucleocapsid protein. Virus Genes 1997, 14, 31-40.
27. 27 Lomonossoff, G.P. and Johnson, J.E. Viral expression systems for peptides. Seminars in Virology 1995, 6, 257-267.
28. 28 Ulrich, R., Gerlich, W.H. and Krüger, D.H. Chimaera and its modern virus-like descendants. Intervirology 1996, 39, 126-132.
29. 29 Pumpens, P., Borisova, G.P., Crowther, R.A. and Grens, E. Hepatitis B virus core particles as epitope carriers. Intervirology 1995, 38, 63-74.
30. 30 Ulrich, R., Borisova, G.P., Gren, E., Berzin, I., Pumpen, P., Eckert, R., Ose, V., Siakkou, H., Gren, E.J., von Baehr, R. and Krüger, D.H. Immunogenicity of recombinant core particles of hepatitis B virus containing epitopes of human immunodeficiency virus 1 core antigen. Archives of Virology 1992, 126, 321-328.
31. 31 Koletzki, D., Zankl, A., Gelderblom, H.R., Meisel, H., Dislers, A., Borisova, G., Pumpens, P., Krüger, D.H. and Ulrich, R., Mosaic hepatitis B virus core particles allow insertion of extended foreign protein segments. Journal of General Virology, 1997, 78, in press.
32. 32 Stohwasser, R., Giebel, L.B., Zöller, L., Bautz, E.K.F. and Darai, G. Molecular characterization of the RNA S segment of Nephropathia epidemica virus strain Hällnäs B1. Virology 1990, 174, 79-86.
33. 33 Borisova, G., Borschukova, O., Mezule, G., Skrastina, D., Petrovskis, I., Dislers, A., Pumpens, P. and Grens, E. Spatial structure and insertion capacity of immunodominant region of hepatitis B core antigen. Intervirology 1996, 39, 16-22.
34. 34 Sambrook, J., Fritsch, E.F. and Maniatis, T., Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1989.
35. 35 Borisova, G.P., Kalis, J.V., Pushko, P.M., Tsibinogin, V.V., Loseva, V.J., Ose, V.P. et al., Gene-engineered mutants of hepatitis B virus core antigen which retain ability to functional self-assembly. Dokl. Akad. Nauk SSSR, 1988, 298 1474-1478. (In Russian.)
36. 36 Stanley, K.K. and Luzio, J.P. Construction of a new family of high efficiency bacterial expression vectors: identification of cDNA clones coding for human liver proteins. EMBO Journal 1984, 3, 1429-1434.
37. 37 Berzins, I., Ulrich, R., Meisel, H., Krüger, D.H., Borisova, G., Pumpens, P., Gren, E., Gelderblom, H., Ladhoff, A.-M., Schnitzler, P., Darai, G. and Bautz, E.K.F. Sites in the core antigen of HBV allowing insertion of foreign epitopes. In: Vaccines 94, ed. E. Norrby, F. Brown, R.M. Chanock and H.S. Girisberg, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1994, pp. 301-308.
38. 38 Spindler, K.R., Rosser, D.S.E. and Berk, A.J. Analysis of adenovirus transforming proteins from early regions 1A and 1B with antisera to inducible fusion antigens produced in Escherichia coli. Journal of Virology 1984, 49, 132-141.
39. 39 Borisova, G., Arya, B., Dislers, A., Borschukova, O., Tsibinogin, V., Skrastina, D., Eldarov, M.A., Pumpens, P., Skryabin, K.G. and Grens, E. Hybrid hepatitis B virus nucleocapsid bearing an immunodominant region from hepatitis B virus surface antigen. Journal of Virology 1993, 67, 3696-3701.
40. 40 Maassen, A., Rehfeldt, A., Kiessig, S., Ladhoff, A., Höhne, W.E. and Meisel, H. Comparison of three different recombinant hepatitis B virus core particles expressed in Escherichia coli. Archives of Virology 1994, 135, 131-142.
41. 41 Gelderblom, H., Bauer, H., Frank, H. and Wigand, R. The structure of group II adenoviruses. Journal of General Virology 1967, 1, 553-560.
42. 42 Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-685.
43. 43 Burnette, W.N. 'Western blotting': electrophoretic transfer of proteins from sodium dodecyl sulfate polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Analytical Biochemistry 1981, 112, 195-203.
44. 44 Elgh, F. Human antibody responses to hantavirus recombinant proteins. Thesis, 1996 (Umeå University Medical Dissertations, New Series No. 482).
45. 45 Niklasson, B., Jonsson, M., Lundkvist, Å., Hörling, J. and Tkachenko, E. Comparison of European isolates of viruses causing hemorrhagic fever with renal syndrome by a neutralization test. American Journal of Tropical Medicine and Hygiene 1991, 45, 660-665.
46. 46 Lundkvist, Å., Hörling, J., Björsten, S. and Niklasson, B. Sensitive detection of hantaviruses by biotin-streptavidin enhanced immunoassays based on bank vole monoclonal antibodies. Journal of Virological Methods 1995, 52, 75-86.
47. 47 Lundkvist, Å., Fatouros, A. and Niklasson, B. Antigenic variation of European haemorrhagic fever with renal syndrome virus strains characterized using bank vole monoclonal antibodies. Journal of General Virology 1991, 72, 2097-2103.
48. 48 Lundkvist, Å., Hörling, J., Athlin, L., Rosén, A. and Niklasson, B. Neutralizing human monoclonal antibodies against Puumala virus, causative agent of nephropathia epidemica: a novel method using antigen-coated magnetic beads for specific B cell isolation. Journal of General Virology 1993, 74, 1303-1310.
49. 49 Von Brunn, A. and Wizemann, H., Hybrid HBc/HIV particles as vaccine candidates against HIV. Workshop 'Chimeric Virus-like Particles as Vaccines', Berlin, 17-19 May 1995, Abstract p. 22.
50. 50 Schödel, F., Moriarty, A.M., Peterson, D.L., Zheng, J., Hughes, J.L., Will, H., Leturcq, D.J., McGee, J.S. and Milich, D.R. The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity. Journal of Virology 1992, 66, 106-114.
51. 51 Pushko, P., Sällberg, M., Borisova, G., Ruden, U., Bichko, V., Wahren, B., Pumpens, P. and Magnius, L. Identification of hepatitis B virus core protein regions exposed or internalized at the surface of HBcAg particles by scanning with monoclonal antibodies. Virology 1994, 202, 912-920.
52. 52 Borschukova, O., Skrastina, D., Dislers, A., Petrovskis, I., Ose, V., Zamurujeva, I. and Borisova, G., Modified hepatitis B core particles as possible vaccine carriers. In Vaccines 97, ed. F. Brown, D. Burton, P. Doherty, J. Mekalanos and E. Norrby, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1997, pp. 33-37.
53. 53 Schirmbeck, R., Böhm, W. and Reimann, J. Virus-like particles induce MHC class I-restricted T-cell responses. Intervirology 1996, 39, 111-119.
54. 54 Lundkvist, Å. and Niklasson, B. Bank vole monoclonal antibodies against Puumala virus envelope glycoproteins: identification of epitopes involved in neutralization. Archives of Virology 1992, 126, 93-105.
55. 55 Del Val, M., Schlicht, H.-J., Volkmer, H.J., Messerle, M., Reddehase, M.J. and Koszinowski, U.H. Protection against lethal cytomegalovirus infection by a recombinant vaccine containing a single nonameric T-cell epitope. Journal of Virology 1991, 65, 3641-3646.
56. 56 Del Val, M., Schlicht, H.-J., Ruppert, T., Reddehase, M.J. and Koszinowski, U.H. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 1991, 66, 1145-1153.
57. 57 Schmaljohn, C.S., Hasty, S.E., Dalrymple, J.M., LeDuc, J.W., Lee, H.W., von Bonsdorff, C.-H., Brummer-Korvenkontio, M., Vaheri, A., Tsai, T.F., Regnery, H.L., Goldgaber, D. and Lee, P.W. Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome. Science 1985, 227, 1041-1044.
58. 58 Chu, Y.-K., Rossi, C., LeDuc, J.W., Lee, H.W., Schmaljohn, C.S. and Dalrymple, J.M. Serological relationships among viruses in the Hantavirus genus, family Bunyaviridae. Virology 1994, 198, 196-204.
59. 59 Hörling, J., Chizhikov, V., Lundkvist, Å., Jonsson, M., Ivanov, L., Dekonenko, A., Niklasson, B., Dzagurova, T., Peters, C.J., Tkachenko, E. and Nichol, S. Khabarovsk, a phylogenetically and serologically distinct Hantavirus isolated from Microtus fortis in Far East Russia. Journal of General Virology 1996, 77, 687-694.